[1] General Office of National Health Commission. Notice on standardizing the comprehensive clinical evaluation of medicines [EB/OL]. (2021-07-21) [2022-10-27]. http://www.nhc.gov.cn/cmssearch/xxgk/getManuscriptXxgk.htm?id=532e20800a47415d84adf3797b0f4869.
[2] National Center for Medicine and Health Technology Assessment (China National Health Development Research Center). Notice on promulgation of technical guidelines for comprehensive clinical evaluation of medicines for cardiovascular diseases, anti-cancer and children [EB/OL]. (2022-06-29) [2022-09-30]. http://www.nhei.cn/nhei/znfb/202206/c01d87a290664b01bf42a9dad769d69f.shtml.
[3] Ministry of Health, National Administration of Traditional Chinese Medicine, Medical Department of General Logistics Department. Provisions on the administration of pharmaceutical affairs in medical institutions [EB/OL]. (2011-01-30) [2022-10-27]. http://www.nhc.gov.cn/yzygj/s3593/201103/4119b5de252d45ac916d420e0d30fda7.shtml.
[4] National Health Commission, Ministry of Education, Ministry of Finance, et al. Notice on issuing opinions on strengthening pharmaceutical administration in medical institutions and promoting rational drug use [EB/OL]. (2020-02-26) [2022-10-27]. http://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac094c47a1fc39cf00f3960e.shtml.
[5] CHENG J, GUAN S J, CAO J L, et al. Expert consensus on the selection of traditional Chinese medicines in medical institutions (first edition) [J]. Chin Pharm J (中国药学杂志), 2022,57(18):1580-1586.
[6] National Health Commission. Notice on the implementation of drug use monitoring and comprehensive clinical evaluation [EB/OL]. (2019-04-09) [2022-10-27]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=31149bb1845e4c019a04f30c0d69c2c9.
[7] Center for Drug Evaluation of National Medical Products Administration. Notice on the publication of the General Format and Guidelines for Writing Instructions for Chemical Drugs and Biological Products [EB/OL]. (2022-05-23) [2022-10-27]. https://www.cde.org.cn/main/news/viewInfoCommon/f181ed96619e3bef4ce8154bb66d91bb.
[8] Center for Drug Evaluation of National Medical Products Administration. Principles for writing instructions of Chinese medicine and natural medicine [EB/OL]. (2007-08-23) [2022-10-27]. https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=e1bc60b52fda24162d77a447b3bf9672.
[9] Project team of Chinese guideline for comprehensive evaluation of drugs. Reference outline of Chinese guideline for comprehensive evaluation of drugs (second edition)[J]. Drug Eval (药品评价), 2015, 12(8): 6-25.
[10] LIU G E, HU S L, WU J H, et al. China Guidelines for Pharmacoeconomic Evaluations (2020) [中国药物经济学评价指南(2020)] [M]. Beijing: China Market Press, 2020.
[11] LIU G E, WU J, XIE F, et al. China Guidelines for Pharmacoeconomic Evaluations: A Manual (2022) [中国药物经济学评价指南导读(2022)] [M]. Beijing: China Market Press, 2022.